𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis

✍ Scribed by Marc G. Achen; Richard A. Williams; Marcel P. Minekus; Gillian E. Thornton; Kaye Stenvers; Peter A. W. Rogers; Fiona Lederman; Sally Roufail; Steven A. Stacker


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
435 KB
Volume
193
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

✦ Synopsis


Expression of angiogenic and lymphangiogenic factors by tumours may influence the route of metastatic spread. Vascular endothelial growth factor (VEGF) is a regulator of tumour angiogenesis, but studies of the inhibition of solid tumour growth by neutralizing anti-VEGF antibodies indicated that other angiogenic factors may be involved. VEGF-D may be an alternative regulator because like VEGF it is angiogenic and it activates VEGF receptor-2 (VEGFR-2), an endothelial cell receptor which is a key signalling molecule in tumour angiogenesis. This study reports the generation of monoclonal antibodies to the receptor-binding domain of VEGF-D and the use of these antibodies to localize VEGF-D in malignant melanoma. VEGF-D was detected in tumour cells and in vessels adjacent to immunopositive tumour cells, but not in vessels distant from the tumours. These findings are consistent with a model in which VEGF-D, secreted by tumour cells, activates endothelial cell receptors and thereby contributes to the regulation of tumour angiogenesis and possibly lymphangiogenesis. In addition, VEGF-D was detected in the vascular smooth muscle, but not the endothelium, of vessels in adult colon. The endothelium of these vessels was negative for VEGFR-2 and VEGFR-3. As VEGF receptors can be up-regulated on endothelium in response to vessel damage and ischaemia, these findings of a specific localization of VEGF-D in smooth muscle of the blood vessels suggest that VEGF-D produced by vascular smooth muscle could play a role in vascular repair by stimulating the proliferation of endothelial cells.


πŸ“œ SIMILAR VOLUMES


Significance of tumour-associated macrop
✍ Helga B. Salvesen; Lars A. Akslen πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 147 KB πŸ‘ 2 views

Angiogenesis is a key process in tumour growth and metastasis, and microvessel density has been found to influence the prognosis of endometrial carcinoma patients. Less is known about regulators of angiogenesis. Studies of other tumour types have indicated that the density of tumourassociated macrop

ACTH-regulated expression of vascular en
✍ Isabelle Gaillard; Michelle Keramidas; Panagiotis Liakos; Isabelle Vilgrain; Jea πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 493 KB πŸ‘ 2 views

Endothelial cells lining vessels of endocrine tissues are fenestrated. Interactions with the local environment via either soluble factors or cell-cell interactions appear to govern this terminal endothelial differentiation. Adrenocorticotropin (ACTH) has previously been reported to modulate endothel

Role of the hypoxia sensing system, acid
✍ Prudence A. E. Scott; Jonathan M. Gleadle; Roy Bicknell; Adrian L. Harris πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 131 KB πŸ‘ 2 views

Vascular endothelial growth factor (VEGF) is a potent angiogenic factor implicated in many pathological processes. We investigated the regulation of 4 alternatively spliced isoforms (121, 165, 189 and 206 amino acids) by hypoxia, hypoglycemia, acidity, female reproductive hormones and vitamin D in b

Plasma levels of vascular endothelial gr
✍ Funmi M. Belgore; Gregory Y. H. Lip; David Bareford; Martin Wadley; Paul Stonela πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 2 views

Raised plasma VEGF is found in some cancers but levels of its receptor soluble Flt-1 (sFlt-1) are unreported. Hypothesising increased levels to be present in haematological cancers, we measured both by ELISA in 22 patients with haematological cancer, 22 with breast cancer, and in age-and sex-matched

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCD
✍ Irena D. Ivnitski-Steele; Megan Friggens; Miquella Chavez; Mary K. Walker πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Abstract ## BACKGROUND 2,3,7,8‐Tetrachlorodibenzo‐__p__‐dioxin (TCDD) exposure prior to chick embryo incubation (GD 0) induces dilated cardiomyopathy, and reduces myocardial hypoxia, vascular endothelial growth factor A (VEGF‐A) expression, and coronary vascularization. We investigated whether